Norihito Inoue

Tokyo, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer.

Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer.

Journal: Cells

Published: April 08, 2026

A case of uterine inflammatory myofibroblastic tumor.

A case of uterine inflammatory myofibroblastic tumor.

Journal: Abdominal radiology (New York)

Published: January 08, 2026

Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity.

Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity.

Journal: Leukemia

Published: December 15, 2025

Myxoid epithelioid smooth muscle tumor with a novel MEF2A::NCOA2 fusion arising in the rectum: case report and literature review.

Myxoid epithelioid smooth muscle tumor with a novel MEF2A::NCOA2 fusion arising in the rectum: case report and literature review.

Journal: Virchows Archiv : an international journal of pathology

Published: August 06, 2025

Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.

Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.

Journal: Pathology international

Published: May 08, 2023

Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.

Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.

Journal: The Journal of dermatology

Published: March 31, 2023

Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.

Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.

Journal: The British journal of dermatology

Published: March 29, 2023

Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.

Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.

Journal: The Journal of dermatology

Published: March 28, 2022

Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine.

Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine.

Journal: Annals of hematology

Published: November 06, 2021

Diffuse large B-cell lymphoma arising immediately after completion of treatment for Hodgkin lymphoma.

Diffuse large B-cell lymphoma arising immediately after completion of treatment for Hodgkin lymphoma.

Journal: EJHaem

Published: July 14, 2021

Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.

Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.

Journal: Leukemia & lymphoma

Published: March 22, 2021

Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.

Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.

Journal: Leukemia & lymphoma

Published: March 10, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026